AB Science annonce a
AB Science annonce avoir reçu de nouvelles autorisations portant sur la reprise des inclusions de ses études de phase 3 du masitinib
14 sept. 2021 12h01 HE | AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR RECU DE NOUVELLES AUTORISATIONS PORTANT SUR LA REPRISE DES INCLUSIONS DE SES ETUDES DE PHASE 3 DU MASITINIB, CONFIRMANT UNE REPRISE GLOBALE DE CES ETUDES...
AB Science announced
AB Science announced that it has received new authorizations to resume patient enrollment in its Phase 3 studies of masitinib
14 sept. 2021 12h01 HE | AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES THAT IT HAS RECEIVED NEW AUTHORIZATIONS TO RESUME PATIENT ENROLLMENT IN ITS PHASE 3 STUDIES OF MASITINIB, CONFIRMING A GLOBAL RESUMPTION OF THESE STUDIES Paris,...